
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Jul 28, 2026 07:40 am UTC| Business
Stellantis has agreed to sell its Free2move car-sharing business to German investment firm Mutares as the global automaker continues to streamline operations and prioritize its core vehicle manufacturing business under CEO...

Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
Jul 28, 2026 02:34 am UTC| Business
Chinese optical components manufacturer Zhongji Innolight has priced its Hong Kong initial public offering (IPO) at HK$980 per H share, raising HK$53.41 billion (US$6.81 billion) in what is set to become Asias...

ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters
Jul 28, 2026 01:49 am UTC| Technology Business
Semiconductor capital equipment stocks tumbled Monday after reports that China has begun mass-producing domestically developed immersion deep ultraviolet (DUV) lithography machines, raising concerns about the future...

Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
Jul 28, 2026 01:39 am UTC| Business Law
Johnson Johnson (NYSE: JNJ) has proposed a $5.5 billion settlement aimed at resolving the vast majority of its remaining U.S. lawsuits alleging that its talc-based products caused ovarian cancer. The healthcare giant said...

Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
Jul 27, 2026 09:06 am UTC| Business
Zabka Group SA (WSE: ZAB) shares tumbled more than 10% on Monday after Japans Seven i Holdings Co. Ltd. (TSE: 3382) decided not to move forward with a potential investment in the Polish convenience store operator,...

Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
Jul 27, 2026 09:04 am UTC| Insights & Views Business Technology
Investor positioning in large-cap technology stocks has fallen sharply from previously elevated levels and is now close to neutral, signaling that the ongoing rotation away from the sector is largely complete, according to...

AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Jul 27, 2026 09:02 am UTC| Business Health
AstraZeneca (LON: AZN) reported stronger-than-expected second-quarter earnings on Monday, reaffirming its 2026 guidance as robust demand for its Oncology and Rare Disease portfolio continued to offset the impact of...